Works matching IS 13520504 AND DT 2017 AND VI 24 AND IP 4

Results: 12

Issue Information.

Published in:: Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 259, doi. 10.1111/jvh.12591
Publication type:: Article

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 262, doi. 10.1111/jvh.12668

By:

El‐Akel, W.;
El‐Sayed, M. H.;
El Kassas, M.;
El‐Serafy, M.;
Khairy, M.;
Elsaeed, K.;
Kabil, K.;
Hassany, M.;
Shawky, A.;
Yosry, A.;
Shaker, M. K.;
ElShazly, Y.;
Waked, I.;
Esmat, G.;
Doss, W.

Publication type:

Article

Cost-effectiveness of elbasvir/grazoprevir use in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 268, doi. 10.1111/jvh.12639

By:

Elbasha, E.;
Greaves, W.;
Roth, D.;
Nwankwo, C.

Publication type:

Article

Cover Image.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. i, doi. 10.1111/jvh.12588

By:

Elbasha, E.;
Greaves, W.;
Roth, D.;
Nwankwo, C.

Publication type:

Article

Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 280, doi. 10.1111/jvh.12641

By:

Alqahtani, S.;
Ozaras, R.;
Isakov, V.;
Wyles, D.;
Ferenci, P.;
Feld, J. J.;
Calinas, F.;
Gschwantler, M.;
Gane, E.;
Crawford, D.;
Jacobson, I. M.;
Dumas, E. O.;
King, M.;
Sulkowski, M.

Publication type:

Article

Determination of hepatitis B phenotype using biochemical and serological markers.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 320, doi. 10.1111/jvh.12643

By:

Di Bisceglie, A. M.;
Lombardero, M.;
Teckman, J.;
Roberts, L.;
Janssen, H. L. A.;
Belle, S. H.;
Hoofnagle, J. H.;
Lau, Daryl T‐Y;
Chung, Raymond T.;
Smith, Coleman I.;
‐Melman, Mauricio;
Wong, David K.;
Juan, Joshua;
Feld, Jordan;
Yim, Colina;
Heathcote, Jenny;
Lee, William M.;
Perrillo, Robert;
Do, Son;
Han, Steven‐Huy B.

Publication type:

Article

HBV/ HCV co-infection is associated with a high level of HCV spontaneous clearance among drug users and blood donors in China.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 312, doi. 10.1111/jvh.12644

By:

Xiong, H.;
Rong, X.;
Wang, M.;
Xu, R.;
Huang, K.;
Liao, Q.;
Huang, J.;
Chen, J.;
Li, C.;
Tang, X.;
Shan, Z.;
Zhang, M.;
Nelson, K.;
Fu, Y.

Publication type:

Article

Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 287, doi. 10.1111/jvh.12645

By:

Lawitz, E.;
Poordad, F.;
Gutierrez, J. A.;
Kakuda, T. N.;
Picchio, G.;
Beets, G.;
Vandevoorde, A.;
Van Remoortere, P.;
Jacquemyn, B.;
Luo, D.;
Ouwerkerk‐Mahadevan, S.;
Vijgen, L.;
Van Eygen, V.;
Beumont, M.

Publication type:

Article

Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 295, doi. 10.1111/jvh.12646

By:

McDonald, S. A.;
Innes, H. A.;
Aspinall, E.;
Hayes, P. C.;
Alavi, M.;
Valerio, H.;
Goldberg, D. J.;
Hutchinson, S. J.

Publication type:

Article

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 304, doi. 10.1111/jvh.12648

By:

Alonso, S.;
Riveiro‐Barciela, M.;
Fernandez, I.;
Rincón, D.;
Real, Y.;
Llerena, S.;
Gea, F.;
Olveira, A.;
Fernandez‐Carrillo, C.;
Polo, B.;
Carrión, J. A.;
Gómez, A.;
Devesa, M. J.;
Baliellas, C.;
Castro, Á.;
Ampuero, J.;
Granados, R.;
Pascasio, J. M.;
Rubín, A.;
Salmeron, J.

Publication type:

Article

The association between hepatitis B self-awareness and depression: Exploring the modifying effects of socio-economic factors.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 330, doi. 10.1111/jvh.12647

By:

Liu, Y.;
Tang, K.;
Long, J.;
Zhao, C.

Publication type:

Article

Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 337, doi. 10.1111/jvh.12649

By:

Chuai, X.;
Chen, P.;
Chen, H.;
Wang, W.;
Deng, Y.;
Ruan, L.;
Li, W.;
Tan, W.

Publication type:

Article